The G1 phase arrest in the melanoma cells after their treatment with anti-miR-106b was associated with marked suppression of the expression of both cyclins and CDKs (CDK2, CDK4 and CDK6) and concomitant reactivation of p21/WAF1/Cip1 protein. The gene discussed is CDKN1A; the disease is melanoma.